EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ring-Finger Protein 126 (RNF126) Promotes Anoikis Resistance and Peritoneal Colonization in Ovarian Cancer

Anh Duc Vu, Shiori Mori, Kanako Akamatsu, Jun Nakayama iD, Takeharu Sakamoto

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262412183 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Anh Duc Vu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Biology, Institute of Biomedical Science, Kansai Medical University, Osaka 573-1010, Japan. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Ovarian Neoplasms, Anoikis, Peritoneal Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology, Kansai Medical University, MEXT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian cancer (OC) represents the most lethal gynecologic malignancy because the majority of patients with OC are diagnosed at advanced stages with peritoneal colonization of OC cells owing to subtle and nonspecific nature of symptoms. Thus, peritoneal colonization-directed therapeutic approaches are urgently needed for patients with advanced OC. Here, we investigated whether Ring-finger protein 126 (RNF126), an E3 ubiquitin ligase that is aberrantly upregulated in epithelial OC tissues, contributes to the peritoneal colonization of OC. RNF126-depleted OC cells showed comparable proliferation under normal culture conditions but displayed decreased growth under floating (anchorage-independent) conditions in vitro. Further analyses showed that RNF126 promoted anoikis resistance in vitro and increased peritoneal colonization in immunodeficient mice in a RING domain-dependent manner. Mechanistically, RNF126 activated the transcriptional factor NF-κB in OC cells under floating conditions in a RING domain-dependent manner, and this NF-κB activation was essential for anchorage-independent growth and peritoneal colonization of OC cells. Thus, RNF126 is a possible target for the prevention and/or therapy of peritoneally colonized OC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ubiquitin-Protein LigasesOvarian NeoplasmsAnoikisPeritoneal NeoplasmsFemaleHumansAnimalsMiceCell Line, TumorNF-kappa BCell ProliferationPeritoneumGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

NF-κBRNF126anoikisovarian cancerperitoneal dissemination

Substanzen

Ubiquitin-Protein LigasesNF-kappa B

Autor:innen und Institutionen

  • Department of Cancer Biology, Institute of Biomedical Science, Kansai Medical University, Osaka 573-1010, Japan.
  • Department of Oncogenesis and Growth Regulation, Research Institute, Osaka International Cancer Institute, Osaka 541-8567, Japan.

ORCID-Profile: Jun Nakayama

Förderung

  • Ministry of Education, Culture, Sports, Science and Technology
  • Kansai Medical University
  • MEXT
  • Kansai Medical University Molecular Imaging Center of Disease
  • Kansai Medical University Research Consortium

Zitieren

APA

Vu, A. D., Mori, S., Akamatsu, K., Nakayama, J., & Sakamoto, T. (2025). Ring-Finger Protein 126 (RNF126) Promotes Anoikis Resistance and Peritoneal Colonization in Ovarian Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262412183

Vancouver

Vu AD, Mori S, Akamatsu K, Nakayama J, Sakamoto T. Ring-Finger Protein 126 (RNF126) Promotes Anoikis Resistance and Peritoneal Colonization in Ovarian Cancer. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262412183

BibTeX
@article{Vu2025,
  author = {Vu, Anh Duc and Mori, Shiori and Akamatsu, Kanako and Nakayama, Jun and Sakamoto, Takeharu},
  title = {Ring-Finger Protein 126 (RNF126) Promotes Anoikis Resistance and Peritoneal Colonization in Ovarian Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262412183}
}
Kostenlos starten →